Home / Health / AI Spots Deadly Melanoma on Routine Check
AI Spots Deadly Melanoma on Routine Check
12 Jul
Summary
- AI technology flagged a suspicious skin lesion, enabling early diagnosis.
- The AI system could significantly reduce patient waiting times for assessments.
- The technology has a high accuracy rate, comparable to human specialists.
A recent case highlights the life-saving potential of artificial intelligence in healthcare. Lindsey Scott, 68, initially overlooked a persistent red mark on her thigh, believing it to be an insect bite. However, after her holiday in August 2024, she sought medical attention and was referred to an NHS pathway utilizing Skin Analytics' AI system, DERM.
This advanced software analyzed high-resolution images of the lesion, immediately flagging it as suspicious. Consequently, Scott bypassed a traditional dermatologist appointment and proceeded directly to surgery for a biopsy. The procedure revealed malignant melanoma, which had already been successfully removed, leading to her recovery.
Skin Analytics' DERM technology has already been implemented in 24 NHS hospitals, assessing over 230,000 patients and identifying more than 20,000 cancers. The company has launched DERM Zero, a version accessible via smartphones, aiming to provide clinical-grade assessments remotely.
Experts believe this AI integration could revolutionize patient entry into the healthcare system, offering immediate assessments for suspicious lesions. This technology not only speeds up diagnosis but also frees up specialist time for those most in need. The aim is not to replace doctors but to enhance their capacity to treat patients requiring urgent care, thereby reducing missed diagnoses and improving survival rates.
